Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001209191-20-032485

Options or other derivatives

  • President and CEO acquired 282,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Owens Julia C. President and CEO 2020-05-25 Grant or award · Stock Option (right to buy) +282,000 282,000 D
Loading xslF345X03/doc4.xml…